Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
56.02
-0.83 (-1.46%)
Apr 17, 2026, 3:04 PM CST

SHE:002653 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,3861,0561,169775.39575.11
Trading Asset Securities
-150.13160.06--
Cash & Short-Term Investments
1,3861,2061,329775.39575.11
Cash Growth
14.94%-9.23%71.37%34.82%-53.41%
Accounts Receivable
1,0331,077883.9803.79569.97
Other Receivables
25.3340.3546.7947.1478.5
Receivables
1,0581,117930.69850.93648.47
Inventory
306.77271.61281.29346259.95
Prepaid Expenses
10.0922.55---
Other Current Assets
72.87112.53100.0281.3264.9
Total Current Assets
2,8342,7302,6412,0541,548
Property, Plant & Equipment
853.21917.09996.041,0741,137
Long-Term Investments
177.99146.99232.46422.17381.19
Other Intangible Assets
1,5181,277751.23708.33682.47
Long-Term Deferred Tax Assets
204.7177.23148.24126.0883.57
Long-Term Deferred Charges
957.531,1071,4271,233822.42
Other Long-Term Assets
465.62443.95457.37430.15350.51
Total Assets
7,0116,7986,6536,0485,005
Accounts Payable
165.85195.89208.99242.44301.4
Accrued Expenses
261.19190.48200.09136.68120.63
Short-Term Debt
79.95242.5799.98484.69452.18
Current Portion of Long-Term Debt
880.74728.41833.59295.4325.78
Current Portion of Leases
7.8410.277.416.648
Current Income Taxes Payable
8.925.4916.0816.11.71
Current Unearned Revenue
16.7220.8714.6126.9628.44
Other Current Liabilities
146.03174.23123.23279.64279.98
Total Current Liabilities
1,5671,5681,5041,4891,518
Long-Term Debt
1,002925854.681,320452.41
Long-Term Leases
9.554.1410.854.5210.91
Long-Term Unearned Revenue
134.7795.06108.4798.52102.54
Long-Term Deferred Tax Liabilities
9.623.774.012.531.11
Other Long-Term Liabilities
--0.38--
Total Liabilities
2,7232,5962,4822,9142,085
Common Stock
1,1201,1201,1141,0761,077
Additional Paid-In Capital
1,085953.57853.38100.8297.62
Retained Earnings
2,1362,1802,2101,8071,733
Treasury Stock
-56.66-80.94-9.15-24.44-38.31
Comprehensive Income & Other
5.7740.5511.8676.41-26.82
Total Common Equity
4,2904,2134,1803,0362,842
Minority Interest
-2-11.09-9.3697.6878.27
Shareholders' Equity
4,2884,2024,1713,1332,920
Total Liabilities & Equity
7,0116,7986,6536,0485,005
Total Debt
1,9801,9101,8072,1111,249
Net Cash (Debt)
-593.2-704.22-477.74-1,336-674.16
Net Cash Per Share
-0.53-0.62-0.44-1.25-0.63
Filing Date Shares Outstanding
1,1551,1591,0481,0361,091
Total Common Shares Outstanding
1,1551,1591,0481,0361,091
Working Capital
1,2671,1621,137565.0930.32
Book Value Per Share
3.713.633.992.932.61
Tangible Book Value
2,7722,9373,4292,3272,159
Tangible Book Value Per Share
2.402.533.272.251.98
Buildings
930.28931.33965.52922.14931.62
Machinery
818.33789.01748.62709.94677.15
Construction In Progress
0.66.735.8797.988.54
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.